Key Takeaways Researchers found four cannabis terpenes significantly reduced chronic pain in animal models. Unlike THC, terpenes do not produce intoxicating effects. The strongest pain-relieving terpene in the study was geraniol. Scientists believe terpenes may become a new class of non-opioid pain medications. Human clinical trials are still needed before terpenes can be recommended as…
Key Takeaways A new Swiss study found that cannabis users had approximately 23% higher testosterone levels than non-users. Researchers analyzed dozens of hormones in young men and found no evidence that cannabis lowers testosterone. The findings challenge a belief that has existed for decades. The study does not prove that cannabis directly increases testosterone. Scientists…
Key Takeaways A large study involving more than 26,000 adults found that cannabis users over 40 showed surprisingly positive brain-related outcomes. Researchers observed larger gray matter volume and better cognitive performance in some cannabis users compared to non-users. The findings challenge decades of traditional anti-cannabis messaging around long-term brain damage. Scientists caution that the study…
Key Takeaways • Psilocin extended human cell lifespan by up to 57% in lab conditions • Psilocybin improved survival rates in aged mice • Effects are linked to reduced oxidative stress, inflammation, and improved cellular resilience • This does not prove a longer human lifespan but highlights anti-aging mechanisms • US policy is shifting rapidly,…
Key Takeaways A 2026 PAX-funded study found vaporizing cannabis reduced measured harmful byproducts by up to 99 percent compared with joint smoke The main source of toxic compounds is combustion, not the cannabis itself The study used controlled lab conditions with a single cannabis batch and measured 16 compounds Results agree with earlier research, but…
Key Takeaways: Terpenes may form a protective layer that prevents viruses like COVID-19 and influenza from entering human cells. CBD and terpenes can reduce inflammation, especially in the lungs, which is crucial during viral infections. Lab tests showed strong antiviral effects, but more research is needed before clinical use. These natural compounds may support vaccines…
Adults with a history of cannabis use may experience better cognitive performance later in life compared to those who have never – or rarely – used cannabis, according to new research published in the Journal of Studies on Alcohol and Drugs. The study was conducted by researchers affiliated with the University of Colorado and Georgia…
Key Takeaways Cannabis may reduce short-term alcohol intake — heavy drinkers consumed up to 27% less alcohol after smoking higher-THC cannabis. Immediate urge to drink decreased, but deeper, long-term alcohol cravings were not consistently reduced. The study used THC-only, smoked cannabis, meaning results may not apply to edibles, vapes, or other cannabinoids like CBD. Participants…
Key Takeaways Frequent cannabis users—especially those diagnosed with cannabis use disorder (CUD)—showed a significantly lower risk of developing alcohol-related liver disease (ALD) compared to non-users. Researchers found up to a 40% reduction in liver disease risk and a 14% lower overall mortality among cannabis users with alcohol use disorder (AUD). CBD may play a key…
Key takeaways Cannabis use among older adults may slow brain aging and is linked to brain patterns typically seen in younger people. Cannabis users performed better in tasks like problem-solving, planning, memory, intelligence, and vocabulary compared to non-users. Benefits were observed from middle age (45–55) through old age (66+), suggesting long-term cognitive advantages. The effect…
Key Takeaways: Daily cannabis use is linked to higher rates of opioid cessation in people with chronic pain Men show stronger associations between daily cannabis use and opioid cessation than women Study examined data from 1,242 people over an eight-year period (2014-2022) Findings add to growing evidence that cannabis may help address the opioid epidemic…
Key Takeaways Experienced medical cannabis patients showed no significant impairment in driving performance after using their typical doses Participants maintained consistent performance in reaction time, lane positioning, and speed adherence THC blood concentrations did not correlate with driving performance Results contradict “zero tolerance” DUI approaches for medical cannabis patients More research needed to develop evidence-based…
Get top cannabis news, legal updates, industry insights and the best deals before everyone else. Sign up today!
